Skip to content

Author

Jin-Chao Zhang

We have 4 of 40 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Bioinspired Photosynthetic Bacterial Dormancy Modulates Gut Microbiota to Potentiate Colorectal Cancer Immunotherapy

Gut microbiota dysbiosis critically limits the efficacy of immunotherapy in colorectal cancer (CRC), motivating the use of oral probiotics as a safe and noninvasive intervention. However, conventional probiotic strategies predominantly rely on gut‐derived commensal bacteria and are constrained by poor gastrointestina...

Yu-Jing Hu, Yi-Chuan Ma, Ying Yang et al. · 0 citations
Aug 2026

Cluster of Differentiation 36-Engineered Photosynthetic Cyanobacteria Enable Immunometabolic Reprogramming in Triple-Negative Breast Cancer.

This work establishes a previously unexplored paradigm for immunometabolic therapy by integrating metabolic checkpoint blockade with photosynthetic oxygenation, providing a promising strategy for immunometabolic remodeling in lipid-rich and hypoxic tumor microenvironments.

Yuanhang Li, Zheng-Xin Yu, Ying Yang et al. · 0 citations
Open access Jul 2026

Modulating Calcium Homeostasis via a Biomimetic Scaffold to Rescue Diabetic Ischemic Wounds

Musc@CP is an advanced dressing that synergistically combines an ECM‐mimetic multi‐property scaffold with active vascular modulation that restoration of blood circulation may contribute to reprogramming the immune microenvironment within the wound, helping to suppress both inflammation and oxidative stress.

Xiang Zheng, Mingmei Li, Jian-Jun Jiang et al. · 0 citations
Open access Jul 2026

A novel pH-responsive nanoreactor for pyroptosis induction: multifaceted ROS amplification drives potent immunotherapy against triple-negative breast cancer

A pH-responsive, pyroptosis-inducing nanoreactor, ZnS/ZIF-90:Fe/Vk3 (ZZFV), designed to elicit potent antitumor immunity, demonstrates potent antitumor efficacy, effectively overcoming immune tolerance in TNBC and achieving robust, sustained antitumor immunity.

Wen-Jia Liu, Ying Wang, Xiang-Yu Hao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.